EXTRAWELL PHAR (00858.HK): Placing Long-Stop Date Extended to 20 November

NewTimeSpace News: On 12 November 2026, Extrawell Pharmaceutical Holdings Limited (stock code: 858) published a supplemental announcement on its placing of new shares under a general mandate, having announced the proposed placing on 30 October and 5 November 2026.

Completion of the placing depends on the conditions of the placing agreement being fulfilled on or before 13 November 2026, or such later date as the Company and the placing agent may agree in writing. As the placing agent needs additional time to procure investors to subscribe for the placing shares, the Company and the placing agent, after arm's length negotiation, entered into a supplemental agreement on 12 November 2026 to revise the long-stop date to 20 November 2026, or such later date as may be agreed in writing.

The placing price of HK$0.052 per placing share represents a discount of about 1.89% to the closing price of HK$0.053 per share quoted on the Stock Exchange on 12 November 2026, the date of the supplemental agreement, and a premium of about 2.36% to the average closing price of about HK$0.0508 per share for the five consecutive trading days immediately before that date. Other terms of the placing agreement remain unchanged. The placing is conditional and may not proceed.